The existence of certain secondary molecular alterations (e.g., TP53, TERT) is usually associated with an increased risk of having a more aggressive and dedifferentiated type of thyroid cancer [15,30] (Figure 1). The gene discussed is TP53; the disease is thyroid gland carcinoma.